Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis

April 21, 2022 updated by: Centre Hospitalier Eure-Seine

Evaluation of Evolution of Perceived Stress in General Practice Residents of Rouen and Caen During COVID-19 Sanitary Crisis

Over the last several years, distress among healthcare professionals is well described, and general practice residents are also affected. Because of COVID-19 sanitary crisis, stress factors are increased, and that may cause anxiety, exhaustion, psychic distress, depression, addictions, or post traumatic stress.

Study Overview

Status

Completed

Conditions

Detailed Description

This prospective non-interventional study aims to evaluate via two questionnaires the evolution of perceived stress in general practice residents of two centres in France, Rouen and Caen. The two questionnaires contain the Perceived Stress Scale, as well as items regarding socio-demographic data and stress factors. The first questionnaire is to be distributed during the epidemic COVID-19 wave and the second questionnaire at the end of the epidemic COVID-19 wave.

Study Type

Observational

Enrollment (Actual)

185

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Évreux, France, 27015
        • CH Eure-Seine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Participants being general practice residents in Caen or Rouen

Description

Inclusion Criteria:

  • Being a general practice resident in Rouen or Caen
  • Participant informed and non-objection of him/her

Exclusion Criteria:

  • Being on maternity leave or not working during the period concerned with the questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of perceived stress during the epidemic wave of COVID19 vs. at the end of the epidemic wave of COVID19
Time Frame: maximum 6 months, according to the evolution of the epidemic
The perceived stress will be evaluated using the Perceived Stress Scale. This scale contains 10 items, with scores ranging from 0 to 40, with higher scores meaning a higher level of stress.
maximum 6 months, according to the evolution of the epidemic

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of general characteristics of residents and their feelings and experiences with the sanitary crisis
Time Frame: maximum 6 months, according to the evolution of the epidemic
This include socio-demographic characteristics, work-related information and potential stress factors
maximum 6 months, according to the evolution of the epidemic
Assessment of residents' profile stress according to their socio-demographic and working characteristics
Time Frame: maximum 6 months, according to the evolution of the epidemic
Identification of stress factors among residents
maximum 6 months, according to the evolution of the epidemic

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ségolène Guillemette, MD, General Practice Physician

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2021

Primary Completion (Actual)

September 24, 2021

Study Completion (Actual)

September 24, 2021

Study Registration Dates

First Submitted

March 1, 2021

First Submitted That Met QC Criteria

March 1, 2021

First Posted (Actual)

March 3, 2021

Study Record Updates

Last Update Posted (Actual)

April 22, 2022

Last Update Submitted That Met QC Criteria

April 21, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-A03283-36
  • CHES N°20/01 (Other Identifier: CH Eure-Seine)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Subscribe